Peter Vorwerk

The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets

Cornelis M. van Tilburg, Elke Pfaff, Kristian W. Pajtler et al. · Cancer Discovery · 2021 · 260 citations · Full text

Medicine, Oncology, Pediatrics +13

THROMBOTECT – a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents

Jeanette Greiner, Martin Schrappe, Alexander Claviez et al. · Haematologica · 2018 · 119 citations · Full text

Medicine, Hematology, Pediatrics +17

Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults

Martina Buehrlen, C. Michel Zwaan, Bernd Granzen et al. · Cancer · 2012 · 118 citations · Full text

Medicine, Oncology, Chemotherapy +8

Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma

Ann-Kathrin Desch, Kristin Hartung, Ante Botzen et al. · Leukemia · 2019 · 84 citations

Medicine, Genetics, Molecular Genetics +14

Outcome and prognostic factors in high‐risk childhood adrenocortical carcinomas: A report from the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT)

Giovanni Cecchetto, Alba Ganarin, Ewa Bień et al. · Pediatric Blood & Cancer · 2016 · 79 citations

Medicine, Oncology, Pediatrics +14